AVNT
Strong BuyFull HouseAI neutralAvient Corporation · Basic Materials · United States · $3.8B cap · $33.7M/day traded
$41.03 +1.1% · close 23 Oct · scored 24 Oct
Full House: Strong business, sensible price, market agrees. The rare full house.
Report expected 4 Nov: the next-year EPS estimate has risen 4.0% over the last 14 weeks.
As of 24 Oct 2026, MoatMap's StockRank for Avient Corporation (AVNT) is 84/100, ranked against 24,000+ stocks in 35 markets (Quality 52, Value 55, Momentum 75, each scored against its sector).
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Avient makes specialty polymer colorants, additives and engineered materials. Its Q2 2026 results showed record margins and raised full-year guidance, and the shares jumped about 12% on the report. That is real execution evidence. However, this is still a materials business whose volumes follow industrial and consumer demand cycles. It carries meaningful debt from its portfolio reshaping and has a sizeable European footprint exposed to higher energy and feedstock costs. The quality and value scores are middling, and there is no clear structural tailwind the market is missing.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT AVIENT CORPORATION
Read
Avient Corporation is a global provider of specialized polymer materials, colorants, and additives, offering tailored solutions that enhance the performance, aesthetics, and sustainability of products across diverse industries. The company distinguishes itself through deep material science expertise and proprietary formulations, catering to high-growth markets such as healthcare, packaging, and electronics. Its strong focus on innovation and custom solutions provides a significant competitive edge in the specialty chemicals sector.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.4B | 3.1B | 3.2B | 3.3B | -1.4% | 3.3B | 3.4B | 3.5B | 4.0% |
| EPS | 7.71 | 0.83 | 1.86 | 0.90 | -51.1% | 1.85 | 1.02 | 1.12 | 11.7% |
| Shares | 90.9M | 91.2M | 91.4M | 91.6M | +0.7% | 91.7M | — | — | — |
| Debt | 2.2B | 2.1B | 2.1B | 2.0B | -3.7% | 1.9B | — | — | — |
| Equity | 2.3B | 2.3B | 2.3B | 2.4B | 0.6% | — | — | — | — |
| Op CF | 398.4M | 201.6M | 256.8M | 301.6M | -8.9% | 299.2M | — | — | — |
| Inv CF | -504.0M | -94.2M | -120.6M | -97.0M | — | — | — | — | — |
| Fin CF | 166.4M | -201.7M | -120.9M | -257.1M | — | — | — | — | — |
Above its 200-day average and 11% below its 52-week high.
Calmer than 60% of stocks we rank over the past year (36% a year).
How this is worked out
StockRank judges the business. The price check reads only the chart: it is the price side of the Momentum score, in words.
The rules: Still falling is a new 52-week low in the last two weeks, at least 25% below the high. Finding a floor is no new low since. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average and within 15% of the high.
In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn like this one cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Basic Materials, ranked by industry match, size, and score similarity. Cross-listings of AVNT are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AVNT | Avient Corporation(you) | $3.8B | 84 | Strong Buy |
| CBT | Cabot Corporation | $3.8B | 82 | Strong Buy |
| ASH | Ashland Inc. | $3.3B | 79 | Buy |
| IOSP | Innospec Inc. | $2.4B | 89 | Strong Buy |
| NEU | NewMarket Corporation | $8.0B | 83 | Strong Buy |
| AXTA | Axalta Coating Systems Ltd. | $7.3B | 80 | Buy |
| BCPC | Balchem Corporation | $5.6B | 71 | Buy |
| KWR | Quaker Chemical Corporation | $2.7B | 69 | Buy |
| WDFC | WD-40 Company | $2.9B | 66 | Buy |
| NGVT | Ingevity Corporation | $2.4B | 69 | Buy |
Peer medians: ROE 1.6% · P/E 20.1x · Gross margin 27.2%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.